Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
Australian culture and pride were very much on display at ISCT 2019, the annual meeting of clinicians, regulators, researchers, technologists and industry who claim membership in the International Society for Cell and Gene Therapy (ISCT). While it was my first time attending an ISCT meeting, CCRM has had a presence there for several years now. […]
It was announced publicly this week that the Ontario Institute for Regenerative Medicine’s (OIRM) funding will not be renewed after March 2020. Closing OIRM would be a significant loss to the regenerative medicine community in Ontario, where so many of Canada’s stem cell and regenerative medicine researchers are located. Kate Allen, Toronto Star, reported the […]
Dear Joe, My worlds collided the other day when I stumbled upon your many, highly viewed stem cell videos on YouTube. You see, my husband is a huge fan of yours. He regularly watches UFC, he practices mixed martial arts and he boxes. He loves your podcast and watches your videos regularly (religiously?). He talks […]
I’m sold. I just watched a fantastic documentary called The Game Changers and I am ready to significantly reduce my meat intake. It may take time to be completely animal-free, but I can certainly consume less meat and farmed fish. I predict that when this documentary gets worldwide distribution, probably in September 2019, it will […]
Rare diseases are defined as such because the number of people affected by them is considered very low. Depending on which country you live in, that number will change. There are so many rare diseases in the world that if you add up the number of people living with one, it’s no longer a small […]
Right Turn: Disappointing news about regenerative medicine funding in Ontario
It was announced publicly this week that the Ontario Institute for Regenerative Medicine’s (OIRM) funding will not be renewed after March 2020. Closing OIRM would be a significant loss to the regenerative medicine community in Ontario, where so many of Canada’s stem cell and regenerative medicine researchers are located. Kate Allen, Toronto Star, reported the […]